Clinical Trial Update: Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy [Phase 2]

View source ↗

Summary

Phase 2 trial comparing oral apixaban to enoxaparin for thromboprophylaxis in women with suspected pelvic malignancy; results completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer
• Venous Thromboembolism

Drugs mentioned

• Apixaban (apixaban)
• Eliquis (apixaban)
• Enoxaparin (enoxaparin sodium)
• Lovenox (enoxaparin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Gynecologic Cancer, Venous Thromboembolism | Phase 2 | Status: COMPLETED | Results posted: 2020-03-31